Cargando…

Real-life effectiveness of anti-malarial treatment regimens: what are we aiming for?

Three-day artemisinin-based combination therapy (ACT) is the current standard of care for the treatment of malaria. However, specific drug resistance associated with reduced efficacy of ACT has been observed, therefore necessitating the clinical development of new anti-malarial drugs and drug combin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mbassi, Dorothea Ekoka, Pfaffendorf, Christoph, Mombo-Ngoma, Ghyslain, Kreuels, Benno, Ramharter, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280843/ https://www.ncbi.nlm.nih.gov/pubmed/37340324 http://dx.doi.org/10.1186/s12936-023-04606-2

Ejemplares similares

Performance of Field’s Stain Compared with Conventional Giemsa Stain for the Rapid Detection of Blood Microfilariae in Gabon
por: Ekoka Mbassi, Franck-A., et al.
Publicado: (2022)

The Supposedly Innocuous Eye Worm: Or, What Could Make You Put Chili in Your Eye?
por: Veletzky, Luzia, et al.
Publicado: (2021)

Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy
por: Mischlinger, Johannes, et al.
Publicado: (2021)

Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin
por: Capan, Mesküre, et al.
Publicado: (2010)

Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: A randomized controlled assessor blinded clinical trial
por: Zoleko-Manego, Rella, et al.
Publicado: (2023)

Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults – a pilot randomized, double-blind, placebo-controlled single-centre phase Ib/IIa clinical trial
por: Ekoka Mbassi, Dorothea, et al.
Publicado: (2023)

Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries
por: Groger, Mirjam, et al.
Publicado: (2023)

Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection
por: Mombo-Ngoma, Ghyslain, et al.
Publicado: (2011)

Adolescence As Risk Factor for Adverse Pregnancy Outcome in Central Africa – A Cross-Sectional Study
por: Kurth, Florian, et al.
Publicado: (2010)

Editorial: What we aim for
por: Stearns, Stephen C.
Publicado: (2015)

Traveling into the Abyss: Risk Perception of German Travelers at the Onset of the COVID-19 Pandemic
por: Shamsrizi, Parichehr, et al.
Publicado: (2020)

Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma
por: Koehne, Erik, et al.
Publicado: (2021)

Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma
por: Koehne, Erik, et al.
Publicado: (2022)

Description of Plasmodium falciparum infections in central Gabon demonstrating high parasite densities among symptomatic adolescents and adults
por: Zoleko Manego, Rella, et al.
Publicado: (2019)

Health Literacy and People with Intellectual Disabilities: What We Know, What We Do Not Know, and What We Need: A Theoretical Discourse
por: Geukes, Cornelia, et al.
Publicado: (2019)

Species and genotype diversity of Plasmodium in malaria patients from Gabon analysed by next generation sequencing
por: Lalremruata, Albert, et al.
Publicado: (2017)

We know what we want, it’s just not there
por: Freundlich, Robert E., et al.
Publicado: (2021)

TAVR in 2017―What we know? What to expect?
por: Kourkoveli, Panagiota, et al.
Publicado: (2018)

Person-first language: are we practicing what we preach?
por: Crocker, Amy F, et al.
Publicado: (2019)

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
por: Guissou, Rosemonde M., et al.
Publicado: (2023)

Malaria in the Time of COVID-19: Do Not Miss the Real Cause of Illness
por: Jochum, Johannes, et al.
Publicado: (2021)

Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations: protocol of a multicentre prospective cohort study (MA-CoV project)
por: Figueroa-Romero, Antía, et al.
Publicado: (2023)

What We Talk About When We Talk About “Junk DNA”
por: Fagundes, Nelson J.R., et al.
Publicado: (2022)

Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria
por: Bassat, Quique, et al.
Publicado: (2022)

Did We Get What We Aimed for 10 Years Ago?
por: Augustinus, A, et al.
Publicado: (2011)

Automated clinical coding: what, why, and where we are?
por: Dong, Hang, et al.
Publicado: (2022)

J Young Pharm. 2011: What are we aiming at?
por: Mueen, Ahmed KK
Publicado: (2011)

Sorting Reality from What We Think We Know About Breast Cancer in Africa
por: Mohammed, Sulma I., et al.
Publicado: (2014)

We are what we eat: Regulatory gaps in the United States that put our health at risk
por: Maffini, Maricel V., et al.
Publicado: (2017)

In vitro growth of Plasmodium falciparum in neonatal blood
por: Sauerzopf, Ulrich, et al.
Publicado: (2014)

What Do We Know About Remdesivir Drug Interactions?
por: Yang, Katherine
Publicado: (2020)

Why are people antiscience, and what can we do about it?
por: Philipp-Muller, Aviva, et al.
Publicado: (2022)

What Happens when Special Needs Children Grow Up?
por: Wilson, Leigh, et al.
Publicado: (2009)

DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambaréné, Gabon
por: Nguyen, The Trong, et al.
Publicado: (2019)

Invasive fungal disease in humans: are we aware of the real impact?
por: Firacative, Carolina
Publicado: (2020)

In medicine, how do we machine learn anything real?
por: Ghassemi, Marzyeh, et al.
Publicado: (2022)

Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon
por: Mombo-Ngoma, Ghyslain, et al.
Publicado: (2012)

Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon
por: May, Jürgen, et al.
Publicado: (2008)

Health insurance system for hematologic diseases: what should we do?
por: Jang, Moon Ju, et al.
Publicado: (2011)

Pathophysiology of periventricular leukomalacia: what we learned from animal models
por: Zaghloul, Nahla, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ecj2irp1eishplvsag4eipmgri